This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Case study: Kidney Research UK perspective on #ComplexInnovativeDesign trials

The NIHR research infrastructure supports the delivery of complex and innovative clinical trials.

Find out more

Fostering collaboration

Complex and Innovative Design (CID) trials have the potential to shorten the drug development time line and get new treatments to patients faster. This is an attractive prospect for research charities like Kidney Research UK which have a strong connection with their patient community.

To that end, Kidney Research UK, has been pivotal in fostering relationships between the life sciences, academia and the NHS in recent years. By supporting dialogue between these sectors, it has enabled a culture of collaboration which has made the UK a prime destination for renal research and is paving the way for a growing number of Complex and Innovative Design (CID) trials.

In these two videos, representatives from Kidney Research UK highlight some of the UK's selling points for renal research. From harnessing the NHS's data capabilities, to connected clinical communities, to the creation of research registries and bio repositories the message is clear - the UK is a world leader in renal research.

Jeremy Hughes is the Chair of Kidney Research UK and the Chair of the UK Kidney Research Consortium.

Jeremy Hughes, Kidney Research UK

Jeremy Hughes is the Chair of Kidney Research UK and the Chair of the UK Kidney Research Consortium.

Michael Nation, Kidney Research UK

Michael Nation is Development Director at Kidney Research UK (KRUK).